✦ LIBER ✦

Safety and efficacy of AN2728 topical ointment, 2% and 0.5%, in a phase II dose-ranging study of adolescents with mild to moderate atopic dermatitis

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety, pharmacokinetics, and efficacy o

📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Safety and efficacy results of a phase I

✍ Salloway, Stephen; Porsteinsson, Anton; Sperling, Reisa; Keren, Ron; van Dyck, C 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 105 KB

Secukinumab efficacy and safety outcomes

📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Efficacy and safety of secukinumab in th

✍ Papp, K.A.; Langley, R.G.; Sigurgeirsson, B.; Abe, M.; Baker, D.R.; Konno, P.; H 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 580 KB

Efficacy and safety of topical WBI-1001

✍ R. Bissonnette; C. Bolduc; C. Maari; S. Nigen; J.M. Webster; L. Tang; M. Lyle 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 243 KB

A Phase 2, Open-label, Investigator-init

✍ Eva Volf; Shiu-Chung Au; Nicole Dumont; Alice Gottlieb 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 38 KB